Beam Therapeutics Inc (BEAM)
24.19
-0.17
(-0.70%)
USD |
NASDAQ |
Nov 05, 11:42
Beam Therapeutics Enterprise Value: 999.48M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 999.48M |
| November 01, 2024 | 881.62M |
| October 31, 2024 | 797.56M |
| October 30, 2024 | 846.19M |
| October 29, 2024 | 818.99M |
| October 28, 2024 | 833.82M |
| October 25, 2024 | 767.89M |
| October 24, 2024 | 812.40M |
| October 23, 2024 | 790.14M |
| October 22, 2024 | 865.97M |
| October 21, 2024 | 899.76M |
| October 18, 2024 | 940.96M |
| October 17, 2024 | 998.65M |
| October 16, 2024 | 1.192B |
| October 15, 2024 | 1.163B |
| October 14, 2024 | 1.183B |
| October 11, 2024 | 1.029B |
| October 10, 2024 | 889.87M |
| October 09, 2024 | 923.66M |
| October 08, 2024 | 908.82M |
| October 07, 2024 | 919.54M |
| October 04, 2024 | 921.18M |
| October 03, 2024 | 882.45M |
| October 02, 2024 | 928.60M |
| October 01, 2024 | 921.18M |
| Date | Value |
|---|---|
| September 30, 2024 | 1.011B |
| September 27, 2024 | 1.056B |
| September 26, 2024 | 1.062B |
| September 25, 2024 | 1.011B |
| September 24, 2024 | 1.033B |
| September 23, 2024 | 1.029B |
| September 20, 2024 | 1.106B |
| September 19, 2024 | 1.138B |
| September 18, 2024 | 1.094B |
| September 17, 2024 | 1.100B |
| September 16, 2024 | 1.103B |
| September 13, 2024 | 1.159B |
| September 12, 2024 | 1.003B |
| September 11, 2024 | 979.70M |
| September 10, 2024 | 940.96M |
| September 09, 2024 | 920.36M |
| September 06, 2024 | 912.94M |
| September 05, 2024 | 984.64M |
| September 04, 2024 | 976.40M |
| September 03, 2024 | 1.003B |
| August 30, 2024 | 1.191B |
| August 29, 2024 | 1.204B |
| August 28, 2024 | 1.139B |
| August 27, 2024 | 1.159B |
| August 26, 2024 | 1.226B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
388.81M
Minimum
Oct 20 2023
7.996B
Maximum
Jul 01 2021
2.367B
Average
1.583B
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 530.78M |
| Electromed Inc | 180.63M |
| Xtant Medical Holdings Inc | 101.94M |
| Myomo Inc | 106.78M |
| Catheter Precision Inc | 2.064M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -91.05M |
| Revenue (Quarterly) | 11.77M |
| Total Expenses (Quarterly) | 116.67M |
| EPS Diluted (Quarterly) | -1.11 |
| Profit Margin (Quarterly) | -773.5% |
| Earnings Yield | -7.48% |
| Normalized Earnings Yield | -7.082 |